September 2019 DMID Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

NB: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Fiscal Year 2021 Concepts

Accelerating Discovery of Efficacious Pre-Erythrocytic Stage Malaria Vaccines

For the published request for applications, see the October 11, 2019 Guide announcement, Accelerating Discovery of Efficacious Pre-Erythrocytic Stage Malaria Vaccines (U01 Clinical Trial Not Allowed).

Rational Design of Vaccines for Hepatitis C

For the published request for applications, see the February 24, 2020 Guide announcement, Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed).

Understanding Phage Biology To Support the Development of Bacteriophage Therapy

For the published request for applications, see the October 10, 2019 Guide announcement, Understanding Phage Biology To Support the Development of Bacteriophage Therapy (R21 Clinical Trial Not Allowed).

Combating Antibiotic-Resistant Bacteria (CARB) Interdisciplinary Research Units

For the published request for applications, see the January 17, 2020 Guide announcement, Combating Antibiotic-Resistant Bacteria (CARB) Interdisciplinary Research Units (U19, Clinical Trial Not Allowed).

Chemistry Center for Antimicrobial Resistance

For the published request for proposals, see the January 15, 2020 solicitation, Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB).

Development of Medical Countermeasures for Biothreat Agents, Antimicrobial-Resistant Infections, and Emerging Infectious Diseases

For the published broad agency announcement, see the February 23, 2021 solicitation, Development of Medical Countermeasures for Biothreat Agents, Antimicrobial-Resistant Infections, and Emerging Infectious Diseases.

International Research in Infectious Diseases

For the published program announcement with special receipt, referral, or review considerations, see the February 4, 2020 Guide announcement, International Research in Infectious Diseases (R01 Clinical Trial Not Allowed).

 

Content last reviewed on